Thailand to make, supply AstraZeneca’s Covid-19 vaccine

Thailand to make, supply AstraZeneca’s Covid-19 vaccine

Thailand has agreed to manufacture and supply AstraZeneca Plc’s experimental Covid-19 vaccine in the kingdom and other nations in the region, the British and Thai governments said on Monday.

The announcement by the British embassy in Bangkok did not specify how many doses of the vaccine candidate, AZD1222, would be distributed in Thailand. It also did not disclose the financial terms of the deal.

AstraZeneca is providing the potential vaccine, developed by scientists at the University of Oxford, at no profit during the pandemic and would work with Siam Bioscience to set up manufacturing facilities, Thailand’s Ministry of Public Health said in a separate statement.

“With the expected technology transfer from AstraZeneca and following Thai FDA regulatory approval, the company is aiming to have the first batch of vaccines available in the middle of next year,” chairman of Siam Bioscience, Satitpong Sukvimol, said.